Pacific Sun Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$315K Buy
1,206
+70
+6% +$17.9K 0.13% 170
2026
Q2
$286K Hold
1,136
– – 0.12% 175
2026
Q1
$247K Hold
1,136
– – 0.12% 180
2025
Q4
$260K Hold
1,136
– – 0.13% 170
2025
Q3
$263K Hold
1,136
– – 0.13% 169
2025
Q2
$211K Hold
1,136
– – 0.11% 178
2025
Q1
$238K Hold
1,136
– – 0.14% 163
2024
Q4
$202K Hold
1,136
– – 0.11% 180
2024
Q3
$224K Buy
+1,136
New +$212K 0.12% 172
2024
Q2
– Sell
-1,136
Closed -$207K – 177
2024
Q1
$207K Buy
+1,136
New +$196K 0.12% 174
2018
Q1
– Sell
-19,581
Closed -$1.89M – 108
2017
Q4
$1.89M Buy
+19,581
New +$1.85M 1.04% 34

Other funds holding ABBV

Pacific Sun Financial's ABBV Position: Q3 2026 in Review

Pacific Sun Financial increased its AbbVie (ABBV) stake by 6.2% in Q3 2026, buying an estimated $17.9K and bringing the position to 1,206 shares worth $315K. The position accounts for 0.13% of the portfolio, ranked #170.

Pacific Sun Financial first reported a position in ABBV in Q4 2017 and has held it in 11 quarters since. The position peaked at $1.89M in Q4 2017. 4,228 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Pacific Sun Financial held 1,206 shares of AbbVie worth $315K as of Q3 2026.
  • Pacific Sun Financial bought 70 AbbVie shares in Q3 2026, an estimated $17.9K.
  • AbbVie made up 0.13% of Pacific Sun Financial's portfolio in Q3 2026, its #170 holding.
  • Pacific Sun Financial first reported a position in AbbVie in Q4 2017 and has held it in 11 quarters since.
  • Pacific Sun Financial's AbbVie position peaked at $1.89M in Q4 2017.
  • 4,228 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Pacific Sun Financial's 13F filing for Q3 2026, filed 13 Nov 2026.